We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.6B
AUM Growth
-$539M
(-2.1%)
Cap. Flow
-$2.74B
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$66.4M |
| 2 |
Microsoft
MSFT
|
+$52.8M |
| 3 |
Mastercard
MA
|
+$39.5M |
| 4 |
Linde
LIN
|
+$28.7M |
| 5 |
Ferrari
RACE
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$160M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$106M |
| 3 |
iShares Morningstar Growth ETF
ILCG
|
+$105M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$104M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 12.29% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AQUA
751
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $2.44M | 0.01% |
128,642
+6,352
| +5% | +$114K |
|
|
LSXMA
752
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $2.37M | 0.01% |
67,823
-12,319
| -15% | -$407K |
|
753
Maximus
MMS
$3.02B
| $2.35M | 0.01% |
31,600
-116,200
| -79% | -$8.73M |
|
754
Travere Therapeutics
TVTX
$5.98B
| $2.35M | 0.01% |
165,400
| – | – |
|
755
Prothena Corp
PRTA
$423M
| $2.32M | 0.01% |
146,709
| – | – |
|
756
Lands' End
LE
$304M
| $2.31M | 0.01% |
137,800
| – | – |
|
757
Fair Isaac
FICO
$21.4B
| $2.31M | 0.01% |
6,157
-15,243
| -71% | -$5.13M |
|
|
TWTR
758
DELISTED
Twitter, Inc.
TWTR
| $2.3M | 0.01% |
71,810
-42,900
| -37% | -$1.41M |
|
759
Universal Health Services
UHS
$10.7B
| $2.3M | 0.01% |
16,044
-10,293
| -39% | -$1.47M |
|
760
Oshkosh
OSK
$8.95B
| $2.28M | 0.01% |
+24,100
| New | +$2.08M |
|
761
Atara Biotherapeutics
ATRA
$101M
| $2.27M | 0.01% |
5,516
+4,727
| +599% | +$1.63M |
|
762
OneMain Financial
OMF
$6.97B
| $2.26M | 0.01% |
+53,600
| New | +$2.17M |
|
763
West Pharmaceutical
WST
$25.5B
| $2.24M | 0.01% |
+14,900
| New | +$2.17M |
|
764
iShares MSCI India Small-Cap ETF
SMIN
$740M
| $2.23M | 0.01% |
+62,100
| New | +$2.19M |
|
765
FNB Corp
FNB
$6.37B
| $2.2M | 0.01% |
173,094
-174,506
| -50% | -$2.14M |
|
766
Crawford & Co Class B
CRD.B
$537M
| $2.19M | 0.01% |
215,929
| – | – |
|
767
Resources Connection
RGP
$139M
| $2.18M | 0.01% |
133,622
| – | – |
|
|
SPR
768
DELISTED
Spirit AeroSystems
SPR
| $2.17M | 0.01% |
29,800
+10,000
| +51% | +$825K |
|
769
Petrobras
PBR
$135B
| $2.17M | 0.01% |
135,844
| – | – |
|
770
Stanley Black & Decker
SWK
$13.4B
| $2.15M | 0.01% |
12,950
-2,484
| -16% | -$385K |
|
771
Carnival Corporation Ltd
CCL
$30.6B
| $2.13M | 0.01% |
41,855
+13,100
| +46% | +$585K |
|
772
Ormat Technologies
ORA
$5.65B
| $2.1M | 0.01% |
+28,158
| New | +$2.13M |
|
773
Trex
TREX
$4.39B
| $2.08M | 0.01% |
+46,400
| New | +$2.04M |
|
774
Blackbaud
BLKB
$2.03B
| $2.07M | 0.01% |
26,000
-13,457
| -34% | -$1.13M |
|
775
JB Hunt Transport Services
JBHT
$22.2B
| $2.04M | 0.01% |
17,465
+15
| +0.1% | +$1.72K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2019 Portfolio in Review
As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.
- Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
- Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
- Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
- Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
- Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
- Axa opened 97 new positions and closed 225 in Q4 2019.
- Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.
Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.